A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Conditions:   Recurrent Langerhans Cell Histiocytosis;   Refractory Langerhans Cell Histiocytosis Interventions:   Procedure: Biospecimen Collection;   Procedure: Bone Marrow Aspiration;   Procedure: Bone Marrow Biopsy;   Procedure: Computed Tomography;   Procedure: Echocardiography;   Procedure: FDG-Positron Emission Tomography and Computed Tomography Scan;   Procedure: Lumbar Puncture;   Procedure: Multigated Acquisition Scan;   Drug: Tovorafenib Sponsor:   National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials